Agios Pharmaceuticals, Inc.Agios Pharmaceuticals, Inc.Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

No trades
See on Supercharts

AGIO fundamentals

Agios Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of AGIO for the last quarter is 8.96 M USD, and it's 4.05% higher compared to the previous quarter. The net income of Q3 24 is 947.91 M USD.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth